The infection prevention department at Ascension Texas managed to shore up IP ranks by calling a couple of IPs out of retirement and asking another if she would postpone her retirement during a COVID-19 surge.
The demographic challenges facing the infection prevention field represent an almost existential threat.1 The hard question must be asked: Will the specialty dry up? Despite the crucial role IPs played in helping patients and their fellow health care professionals weather COVID-19 surges, the post–COVID-19 normal might dishearteningly resemble the pre–COVID-19 normal. IPs again may start to feel underappreciated2 and underutilized,3 while their ranks continue to thin. It’s a situation much on the minds of working IPs,4 including those who are APIC officials, as they lobby US states to mandate that NHs and other long-term care facilities hire full-time IPs, and encourage hospitals to layer the IP career path5—novice, becoming proficient, proficient, and expert—through training programs that are often tied to teaching institutions.
In the meantime, though…there’s the meantime. A study6 unveiled last month at APIC’s annual conference looked at a creative approach to keep infection prevention departments fully staffed while also giving younger health care workers who want to become IPs the training they need.
The infection prevention department at Ascension Texas managed to shore up IP ranks by calling a couple of IPs out of retirement and asking another if she would postpone her retirement during a COVID-19 surge. The 3 IPs helped with remote monitoring, thereby freeing the IPs on site to take a more hands-on approach.
“The [retired] IPs required no onboarding or training due to prior knowledge of surveillance methodology, electronic health records, and surveillance software systems,” writes study author Holly Taylor, MPH, CIC, the infection prevention director at Ascension Texas in the study. “An [as-needed] status was preferred over [full-time] or part-time status by both the IPs and the organization. Full-time IPs reported increased availability for unit-based activities.”
Taylor relates to ICT® that not only did the retired IPs help with the workload, they also helped ease new IPs into the profession. “When you are a novice coming into infection prevention, there is so much content, so much work. It’s incredibly fast-paced,” she tells ICT®. “And we know novice IPs often come in without a lot of support. The attrition rate is pretty high. So even just being able to offload some of those administrative tasks, administrative burden, to help facilitate a [better] learning environment, [was appreciated]. I’ve had feedback from my novice IPs talking about how much [the program] has given them space to learn the profession, develop competency in key areas.”
Experienced IPs also found interacting with the retired IPs to be an educational experience.
“I have one who was an endoscopy manager for an extended period of time,” says Taylor. “She brings just a really invaluable set of skills and level of expertise related to high-level disinfection of endoscopes, and so she has come in to round with folks or get perspectives and give feedback, consult with them, to help prioritize any follow-up actions, and so forth.”
Taylor hopes that the arrangement might be more than a stopgap. Ascension Texas administrators so far have made no indication that they want to end the program even as COVID-19 ebbs.
“I know that they are helping support and work through expanding the staffing complement of my department,” Taylor tells ICT®. “I see this as something that they allow me to keep for a while. I have not heard that they have put an end date on it for me at all.”
References:
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.